Invest smarter and fundraise faster
Jointly built by Bain & Company and CEPRES, DealEdge is a powerful, intuitive digital advisory product that gives private equity investors unprecedented insight into which deals have the most potential and where hidden opportunities exist to create value.
Find out moreManage your deal pipeline
Triage your deal pipeline and focus your efforts on the most promising investments. Review past returns for your target sectors and consider potential adjacency plays and opportunities.
Prove your investment thesis
See how your performance measures up to your peers. Understand how value was created in past deals to pressure test your investment thesis. Highlight your successes and strengths to LPs.
Add a new analytical layer to your deals
Inform your decision-making and gain insights based on cash flow and aggregated, operating market intelligence from more than 35,000 private market deals by conducting granular analysis.
Leverage the most sophisticated taxonomy developed by Bain’s market-leading consultants. DealEdge data is broken down into 560 industries, sectors and sub-sectors classifications.
Leverage data based on 50,000 buyout and growth deals, highlighting new opportunities and potential to unlock alpha.
Leverage more than 20 out of the box analyses on IRR, multiples, value creation and more, allowing you to spend time analyzing data rather than formatting worksheets.
Generate instant analytics to power better investment decisions
With DealEdge, inform your decision making and gain insights based on cash flow and aggregated, operating market intelligence from more than 35K private market deals. Conduct granular analysis on the most accurate, actionable private market data.
It is very easy to build and use dashboards on the product – it takes no time to learn. And if we do need assistance, the DealEdge team is very helpful and responsive!
Brady Akman Director of Business Development – Healthcare Welsh, Carson, Anderson & Stowe
Insights
Introducing the DealEdge Free Trial: Unlock Market Insights with CEPRES Data
We’re excited to introduce the DealEdge Free Trial, powered by CEPRES' exclusive data. With the launch of this free trial, we’re also proud to announce that DealEdge has crossed the threshold to over 50,000 deals, covering 570+ subsectors and 200+ countries from 1970 to 2024.
How will the decline in interest rates affect the private capital markets?
The twenty-first century has experienced a range of different interest rate regimes - from the aperiodic near-zero interest rate environment of most of the 2010s to the fluctuations seen in the early 2000s, and now again (more sharply) in the 2020s.
CEPRES' Private Credit Outlook for 2024-2025
As we move into 2025 with a 50 basis point rate cut already implemented, private credit faces a mixed yet promising outlook. Private credit is directly impacted by these rate changes.
Introducing the DealEdge Free Trial: Unlock Market Insights with CEPRES Data
We’re excited to introduce the DealEdge Free Trial, powered by CEPRES' exclusive data. With the launch of this free trial, we’re also proud to announce that DealEdge has crossed the threshold to over 50,000 deals, covering 570+ subsectors and 200+ countries from 1970 to 2024.
How will the decline in interest rates affect the private capital markets?
The twenty-first century has experienced a range of different interest rate regimes - from the aperiodic near-zero interest rate environment of most of the 2010s to the fluctuations seen in the early 2000s, and now again (more sharply) in the 2020s.
CEPRES' Private Credit Outlook for 2024-2025
As we move into 2025 with a 50 basis point rate cut already implemented, private credit faces a mixed yet promising outlook. Private credit is directly impacted by these rate changes.